Regulus Therapeutics reported $52.13M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
AstraZeneca AZN:LN USD 94.18B 2.39B
Astrazeneca AZN:US USD 94.18B 2.39B
Biogen BIIB:US USD 24.85B 227.2M
Celldex Therapeutics CLDX:US USD 369.23M 33.74M
Gilead Sciences GILD:US USD 62.56B 313M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Intrexon XON:US USD 259.24M 61.98M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Lexicon Pharmaceuticals LXRX:US USD 191.68M 79.36M
Ligand Pharmaceuticals LGND:US USD 1.05B 25.68M
Omeros OMER:US USD 457.55M 111.91M
Regulus Therapeutics RGLS:US USD 52.13M 2.17M
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Spectrum Pharmaceuticals SPPI:US USD 118.93M 39.5M
Takeda 4502:JP JPY 14.59T 523.42B
Vital Therapies VTL:US USD 121.08M 17.57M
YTE INCY:US USD 5.51B 191.18M